Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhTPO plus IVIg for ITP in Pregnancy
NCT05634824Phase 2Unknown
- Sponsor
- Peking University People's Hospital
- Start
- Jan 2023
- Primary completion
- Jan 2023
- Modality
- Cytokines & Interferons
01
Overview
A Phase 2 trial of recombinant human thrombopoietin in immune thrombocytopenia (ITP), sponsored by Peking University People's Hospital. Status: unknown.
02
Drugs
recombinant human thrombopoietin
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT05634824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05634824.